Format

Send to

Choose Destination
Rev Diabet Stud. 2005 Fall;2(3):121-35. Epub 2005 Nov 10.

B cells in autoimmune diabetes.

Author information

1
Department of Cellular and Molecular Medicine, University of Bristol, University Walk, Bristol BS8 1TD, United Kingdom. susan.wong@bristol.ac.uk

Abstract

Autoantibodies have been used as good markers for the prediction of future development of type 1 diabetes mellitus (T1DM), but are not thought to be pathogenic in this disease. The role of B cells that produce autoantibodies in the pathogenesis of human T1DM is largely unknown. In the non-obese diabetic (NOD) mouse model of autoimmune diabetes, it has been shown that B cells may contribute multifariously to the pathogenesis of the disease. Some aspects of deficiencies of B cell tolerance may lead to the circulation of autoreactive B cells. In addition, the antigen-presenting function of autoantigen specific B cells is likely to be particularly important, and autoantibodies are also considered to play a critical role. This review discusses the possible aspects of B cells involved in the development of autoimmune diabetes.

Supplemental Content

Full text links

Icon for Society for Biomedical Diabetes Research Icon for PubMed Central
Loading ...
Support Center